Literature DB >> 4713941

In vivo behavior of fibrinogen fragment D in experimental renal, hepatic and reticuloendothelial dysfunction.

O A Hayne, L A Sherman.   

Abstract

Fibrinogen Fg-D, obtained by plasmin-induced cleavage of fibrinogen, was separated and purified by ion exchange chromatography. The in vivo behavior was studied by administering 2 mg of (125)I-labeled Fg-D intravenously into each of 3 normal, 3 partially hepatectomized, 3 reticuloendothelial system (RES) blockaded, 4 nephrectomized and 2 ureter ligated rabbits. The plasma clearance in normal rabbits showed two components: 66.0 +/- 6.0% was cleared with a t(1/2) of 0.9 +/- 0.2 hours and 32.3 +/- 5.3% cleared with a t(1/2) of 3.6 +/- 0.3 hours. In both the partially hepatectomized and RES-blockaded groups, the clearance patterns were similar to those observed in the normal animals. In contrast, in the nephrectomized group, while the t(1/2) of the first component was similar to that in the normal group, the second component had a longer t(1/2) (6.0 +/- 1.0 hours) than the other groups. In the animals with both ureters occluded, the t(1/2)'s were similar to the normal animals. Measurements of urinary radioactivity suggested that complete in vivo catabolism had occurred. In vivo subfragments of Fg-D could not be detected in the plasma. Neither Fg-D nor subfragments were found in the urine. These results indicate that Fg-D is rapidly cleared from the plasma, that in vivo subfragmentation does not occur, and that the kidneys are important in the catabolism of a portion of Fg-D.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4713941      PMCID: PMC1903957     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

2.  A modified ninhydrin reagent for the photometric determination of amino acids and related compounds.

Authors:  S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

3.  Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.

Authors:  M W Mosesson; J S Finlayson; R A Umfleet; D Galanakis
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

4.  Plasmic degradation of fibrinogen.

Authors:  P Wallén
Journal:  Scand J Haematol Suppl       Date:  1971

5.  Formation of highly ordered polymers from fibrinogen and fibrin degradation products.

Authors:  S Niewiarowski; G J Stewart; V J Marder
Journal:  Biochim Biophys Acta       Date:  1970-11-17

6.  Split products of fibrin in human renal disease.

Authors:  E R Stiehm; C W Trygstad
Journal:  Am J Med       Date:  1969-05       Impact factor: 4.965

7.  Clearance of coagulation and fibrinolysis products by the reticuloendothelial system.

Authors:  R T Walsh; M I Barnhart
Journal:  Thromb Diath Haemorrh Suppl       Date:  1969

8.  The uptake of fibrin and fibrin-degradation products by the isolated perfused rat liver.

Authors:  H Gans; J T Lowman
Journal:  Blood       Date:  1967-04       Impact factor: 22.113

9.  The preparation and properties of human fibrinogen of relatively high solubility.

Authors:  M W Mosesson; S Sherry
Journal:  Biochemistry       Date:  1966-09       Impact factor: 3.162

10.  Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction.

Authors:  L LEE
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

View more
  3 in total

1.  Immunoenzyme histochemical localization of fibrin degradation products in tissues.

Authors:  J J Emeis; J Lindeman; W Nieuwenhuizen
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

2.  Specific binding of soluble fibrin to macrophages.

Authors:  L A Sherman; J Lee
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

3.  Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion.

Authors:  Heiko Rühl; Christina Berens; Anna Winterhagen; Jens Müller; Johannes Oldenburg; Bernd Pötzsch
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.